{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:10:29Z","timestamp":1758931829636,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.biomaterials.2009.11.039","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T06:35:57Z","timestamp":1260513357000},"page":"1773-1779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis"],"prefix":"10.1016","volume":"31","author":[{"given":"Yi-Jie","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Wei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hwa","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Jung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2009.11.039_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib2","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ajo.2007.12.001","article-title":"AIDS and ophthalmology: the first quarter century","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/AAC.49.3.873-883.2005","article-title":"Human cytomegalovirus resistance to antiviral drugs","volume":"49","author":"Gilbert","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bjo.78.2.120","article-title":"High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS","volume":"78","author":"Diaz-Llopis","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1. ocular diagnoses at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1310\/9M23-QN0X-W6N8-80JD","article-title":"Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis","volume":"7","author":"Walmsley","year":"2006","journal-title":"HIV Clin Trials"},{"issue":"3","key":"10.1016\/j.biomaterials.2009.11.039_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9394(00)00785-6","article-title":"High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis","volume":"131","author":"Velez","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"Suppl. 1","key":"10.1016\/j.biomaterials.2009.11.039_bib11","first-page":"11","article-title":"Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet","volume":"4","author":"Jacobson","year":"1991","journal-title":"J AIDS"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.34.2.373","article-title":"Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro","volume":"34","author":"Manischewitz","year":"1990","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(89)90030-2","article-title":"Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo","volume":"12","author":"Freitas","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-4636(1999)48:5<613::AID-JBM4>3.0.CO;2-#","article-title":"In vitro elution of antibiotics from biodegradable beads","volume":"48","author":"Liu","year":"1999","journal-title":"J Biomed Mat Res (Applied Biomaterials)"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2008.11.024","article-title":"In vitro elution of vancomycin\/amikacin\/steroid from solvent-free biodegradable scleral plugs","volume":"370","author":"Liu","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s004170050031","article-title":"Biodegradable scleral implant for intravitreal controlled release of ganciclovir","volume":"238","author":"Yasukawa","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/jm00359a023","article-title":"9-[(1,3-Dihydroxy-2-propoxy)methyl] guanine: a new potent and selective antiherpes agent","volume":"26","author":"Martin","year":"1983","journal-title":"J Med Chem"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.24.4.518","article-title":"Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro","volume":"24","author":"Mar","year":"1983","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/AAC.25.2.247","article-title":"Effects of the nucleoside analog 2\u2032-nor-2\u2032-deoxyguanosine on human cytomegalovirus replication","volume":"25","author":"Tocci","year":"1984","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/infdis\/152.4.833","article-title":"Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine","volume":"152","author":"Plotkin","year":"1985","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/AAC.33.5.663","article-title":"Combinations of 3\u2032-azido-3\u2032-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro","volume":"33","author":"Eriksson","year":"1989","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-3542(96)00947-3","article-title":"Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro","volume":"31","author":"Hostetler","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000149156","article-title":"Reversible inhibition of cytomegalovirus replication by phosphonoformate","volume":"14","author":"Wahren","year":"1980","journal-title":"Intervirology"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/17453679508995563","article-title":"In vitro elution of ofloxacin from a bioabsorbable polymer","volume":"66","author":"Nie","year":"1995","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.2042-7158.1994.tb03890.x","article-title":"Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties","volume":"46","author":"Zhang","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-3659(90)90152-J","article-title":"Mechanistic studies of macromolecular drug release from macroporous polymers. Models for the flow kinetics of drug release","volume":"14","author":"Siegel","year":"1990","journal-title":"J Control Release"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib27","first-page":"1038","article-title":"Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir","volume":"35","author":"Berthe","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5694\/j.1326-5377.1992.tb137242.x","article-title":"High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis","volume":"157","author":"Young","year":"1992","journal-title":"Med J Aust"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1076\/ceyr.16.7.633.5063","article-title":"Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits","volume":"16","author":"Hashizoe","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib30","first-page":"1024","article-title":"Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits","volume":"42","author":"L\u00f3pez-Cort\u00e9s","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3928\/1542-8877-19950901-12","article-title":"Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS","volume":"26","author":"Duker","year":"1995","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0161-6420(00)00023-3","article-title":"Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis","volume":"107","author":"Macdonald","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biomaterials.2009.11.039_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1310\/4J65-4YX1-4ET6-E5KR","article-title":"The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy","volume":"6","author":"Wohl","year":"2005","journal-title":"HIV Clin Trials"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961209012678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961209012678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:17:55Z","timestamp":1758899875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961209012678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0142961209012678"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2009.11.039","relation":{},"ISSN":["0142-9612"],"issn-type":[{"type":"print","value":"0142-9612"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2009.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}